✦ LIBER ✦

Salvage chemotherapy with paclitaxel, ifosfamide, and nedaplatin in patients with urothelial cancer who had received prior cisplatin-based therapy

✍ Scribed by Nobuo Shinohara; Toru Harabayashi; Shin Suzuki; Kazuhiro Nagao; Haruo Seki; Masashi Murakumo; Kimiyoshi Mitsuhashi; Takayoshi Demura; Satoshi Nagamori; Hideyasu Matsuyama; Katsusuke Naito; Katsuya Nonomura

Publisher: Springer
Year: 2006
Tongue: English
Weight: 214 KB
Volume: 58
Category: Article
ISSN: 0344-5704
DOI: 10.1007/s00280-005-0175-4

No coin nor oath required. For personal study only.

📜 SIMILAR VOLUMES

Gemcitabine and paclitaxel chemotherapy

Gemcitabine and paclitaxel chemotherapy for advanced urothelial carcinoma in patients who have received prior cisplatin-based chemotherapy

✍ Kunimitsu Kanai; Eiji Kikuchi; Takashi Ohigashi; Akira Miyajima; Ken Nakagawa; J 📂 Article 📅 2008 🏛 Springer 🌐 English ⚖ 296 KB

Chemotherapy with an every-2-week regime

Chemotherapy with an every-2-week regimen of gemcitabine and paclitaxel in patients with transitional cell carcinoma who have received prior cisplatin-based therapy

✍ Cora N. Sternberg; Fabio Calabrò; Giorgio Pizzocaro; Luca Marini; Sylvia Schnetz 📂 Article 📅 2001 🏛 John Wiley and Sons 🌐 English ⚖ 66 KB 👁 2 views

Salvage chemotherapy with paclitaxel and

Salvage chemotherapy with paclitaxel and gemcitabine plus nedaplatin (TGN) as part of multidisciplinary therapy in patients with heavily pretreated cisplatin-refractory germ cell tumors

✍ Takumi Shiraishi; Terukazu Nakamura; Kazuya Mikami; Natsuki Takaha; Akihiro Kawa 📂 Article 📅 2009 🏛 Springer 🌐 English ⚖ 236 KB